STOCK TITAN

Privia Health Group, Inc. - $PRVA STOCK NEWS

Welcome to our dedicated page for Privia Health Group news (Ticker: $PRVA), a resource for investors and traders seeking the latest updates and insights on Privia Health Group stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Privia Health Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Privia Health Group's position in the market.

Rhea-AI Summary
PRVA Announces Strong Q2 2023 Results, Practice Collections +13.7%, Net Income $7.3M, and Implementation in Washington State
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.67%
Tags
-
News
Rhea-AI Summary
Privia Health Group has signed an agreement to enter the state of Washington in partnership with Walla Walla Clinic, a multi-specialty practice. The partnership aims to offer high-quality care to patients in the community and expand Privia's presence on the West Coast. Walla Walla Clinic will serve as the anchor practice for Privia Medical Group — Washington. The transaction is expected to close in the third quarter, and Walla Walla Clinic will be implemented on the Privia Platform by the end of 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.79%
Tags
none
-
Rhea-AI Summary
Privia Health Group, Inc. announces the election of David Wichmann and Pamela Kimmet to its Board of Directors. Wichmann brings expertise in value-based care and healthcare innovation, while Kimmet has extensive human capital expertise. Their addition to the board will support Privia Health's growth and expansion as a national leader in physician enablement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.48%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.26%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.38%
Tags
management
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.67%
Tags
conferences
Rhea-AI Summary
Privia Health Group, Inc. announces upsized pricing of secondary offering of common stock by certain selling stockholders. New investors include Durable Capital Partners LP and Rubicon Founders LLC.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.22%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.22%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.22%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.22%
Tags
Privia Health Group, Inc.

Nasdaq:PRVA

PRVA Rankings

PRVA Stock Data

2.22B
94.19M
8.77%
96.06%
5.65%
Dental Laboratories
Manufacturing
Link
United States of America
ARLINGTON

About PRVA

we believe this is the most exciting time in history to be involved in healthcare. our team is leading transformative change; rapidly evolving the system from “sick care” to “well care.” we think life’s too short not to do something with passion, and here at privia we’re doing something that makes a tangible difference. we look for people with that passion. people who want to experience life to the fullest. people who are curious, resourceful, hard working, and tenacious. people who disdain the status quo. our culture is made up of people who look at the world and see opportunity, and who aren’t afraid to dive right in, experience life, and make that opportunity happen.